. 1956 Mar;63(2):150-64.

Venezulean equine encephalomyelitis; laboratory aspects of fourteen human cases following vaccination and attempts to isolate the virus from the vaccine

D G SMITH et al. Am J Hyg. 1956 Mar.

. 1956 Mar;63(2):150-64.

No abstract available

Cited by

Purification, concentration, and inactivation of Venezuelan equine encephalitis virus.
Gruber J. Gruber J. Appl Microbiol. 1970 Sep;20(3):427-32. doi: 10.1128/am.20.3.427-432.1970. Appl Microbiol. 1970. PMID: 4922154 Free PMC article.
Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.
Rusnak JM, Dupuy LC, Niemuth NA, Glenn AM, Ward LA. Rusnak JM, et al. Comp Med. 2018 Oct 1;68(5):380-395. doi: 10.30802/AALAS-CM-18-000027. Epub 2018 Oct 3. Comp Med. 2018. PMID: 30282570 Free PMC article.
Gamma-irradiated Venezuelan equine encephalitis vaccines.
Reitman M, Tribble HR Jr, Green L. Reitman M, et al. Appl Microbiol. 1970 May;19(5):763-7. doi: 10.1128/am.19.5.763-767.1970. Appl Microbiol. 1970. PMID: 5463575 Free PMC article.
Inactivation of Venezuelan Equine Encephalomyelitis Virus by gamma-Radiation.
Reitman M, Tribble HR. Reitman M, et al. Appl Microbiol. 1967 Nov;15(6):1456-9. doi: 10.1128/am.15.6.1456-1459.1967. Appl Microbiol. 1967. PMID: 16349765 Free PMC article.
Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
Martin SS, Bakken RR, Lind CM, Garcia P, Jenkins E, Glass PJ, Parker MD, Hart MK, Fine DL. Martin SS, et al. Vaccine. 2010 Apr 19;28(18):3143-51. doi: 10.1016/j.vaccine.2010.02.056. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20193792 Free PMC article.